The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch
|
|||||
|
       
  |
University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market. . . . → Read More: Health Research Commercialization Company Launched 
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals 
A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution 
A spin-off company from a university engineering lab received funds to build a device that efficiently splits water and creates hydrogen for fuel cell cars. . . . → Read More: Start-Up Gains Hydrogen Fuel Technology Funds 
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits 
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections. . . . → Read More: Antibody Neutralizes Covid-19, SARS Viruses 
A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders. . . . → Read More: Pharmas License A.I.-Aided Gene Therapies  Comments are closed  Intellectual property  biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, university 
A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease Comments are closed Intellectual property Asia, biomedical, biotechnology, clinical trials, Europe, FDA, Japan, licensing, life sciences, pharmaceuticals, stem cells 
A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr. . . . → Read More: [Updated] Fast Paper Strip Covid-19 Test Devised with Crispr One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, engineering, genomics, licensing, life sciences, medical device, physical sciences, university |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||